Osteoarthritis; Human Health; Veterinary.

4P-Pharma is a French biotech company, specialized in the development of therapeutic molecules for several indications (inflammation, cancer, and rare diseases) in collaboration with Universities and Biotech companies, from drug discovery level up to clinical phase I/II.

Since our creation in 2014, we have screened >200 early-stage projects, among whom 10 projects entered in wet diligence in our laboratories for proof of concept and technical validation. One technology out of the 10 tested passed our validation criteria and is today one of our lead projects. This drug aims at treating OsteoArthritis, with applications for Human and Animal use, and is now approaching clinical phase II.

In parallel, we continue the development of early-stage drugs for highly unmet medical needs.